| NCT ID | NCT03699228 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beijing Jishuitan Hospital |
| Condition | Osteoporosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 30,000 participants |
| Start Date | 2017-12-01 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30,000 participants in total. It began in 2017-12-01 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this nationwide multi center study the investigators combine the low dose chest CT scan data with QCT technology, to measure the BMD of spine, VAT and liver fat in the health check subjects. The aim of this study is to evaluate the performance of QCT in the health check field, and further to evaluate the prevalence of osteoporosis, obesity and liver steatosis in health check population across China.
Eligibility Criteria
Inclusion Criteria: health check subjects 30-90 years old low dose chest CT scan Exclusion Criteria: pregnant women metal implant in the CT scan area
Contact & Investigator
xiaoguang cheng, MD
PRINCIPAL INVESTIGATOR
Beijing Jishuitan Hospital
Frequently Asked Questions
Who can join the NCT03699228 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 90 Years, studying Osteoporosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03699228 currently recruiting?
Yes, NCT03699228 is actively recruiting participants. Contact the research team at xiao65@263.net for enrollment information.
Where is the NCT03699228 trial being conducted?
This trial is being conducted at Wuhu, China, Beijing, China, Guiyang, China, Zhengzhou, China and 2 additional locations.
Who is sponsoring the NCT03699228 clinical trial?
NCT03699228 is sponsored by Beijing Jishuitan Hospital. The principal investigator is xiaoguang cheng, MD at Beijing Jishuitan Hospital. The trial plans to enroll 30,000 participants.